14.45 USD
↘ 0.68 (4.49%)AT CLOSE (03:59 PM EDT)
Sutro Biopharma, Inc.
STRONASDAQ • USD
14.45
↘ 0.00 (0.03%)
POST MARKET (AS OF 04:27 PM EDT)
Post Market
AS OF 04:27 PM EDT
14.45
↘ 0.00 (0.03%)
Market: OPEN
Sutro Biopharma, Inc. (STRO) trades at $14.45 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (174.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. STRO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 5, 2026.
Open?$15.14
High?$15.47
Low?$14.37
Prev. Close?$15.13
Volume?162.1K
Avg. Volume?280.6K
VWAP?$14.64
Rel. Volume?0.58x
Bid / Ask
Bid?$9.28 × 100
Ask?$16.49 × 100
Spread?$7.21
Midpoint?$12.88
Valuation & Ratios
Market Cap?250.9M
Shares Out?16.6M
Float?15.0M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?-2.43
EPS?-$10.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Themes
Employees
128
Market Cap
250.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-09-27
Address
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?50
Short Sent.?55
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.58Distress
Confidence?61%Moderate
Short InterestHigh
Short % of Float?13.83%High
Short Interest?2.1M
Days to Cover?6.0
Free Float15.0M
Avg Daily Volume346.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.32Strong
Quick Ratio?3.32Strong
Cash Ratio?1.03Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?-2.43CHEAP▾
S&P97
P/S?5.49FAIR▾
Peers100
S&P26
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?4.30FAIR▾
Peers100
S&P43
Returns & Efficiency
ROE?174.8%STRONG▾
Peers50
S&P97
ROA?-92.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-145619000
Enterprise Value?$196.5M
Fundamentals ratios updated end of day